Mirae Asset Global ETFs Holdings
TARS icon

Mirae Asset Global ETFs Holdings’s Tarsus Pharmaceuticals TARS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
19,206
+650
+4% +$41.5K ﹤0.01% 1536
2026
Q1 		$1.3M Buy
18,556
+363
+2% +$25.4K ﹤0.01% 1395
2025
Q4 		$1.49M Buy
18,193
+66
+0.4% +$4.93K ﹤0.01% 1305
2025
Q3 		$1.08M Sell
18,127
-3,117
-15% -$153K ﹤0.01% 1444
2025
Q2 		$861K Sell
21,244
-899
-4% -$40.5K ﹤0.01% 1527
2025
Q1 		$1.14M Buy
22,143
+1,217
+6% +$60.2K ﹤0.01% 1437
2024
Q4 		$1.16M Buy
20,926
+724
+4% +$32.9K ﹤0.01% 1474
2024
Q3 		$664K Buy
20,202
+5,559
+38% +$156K ﹤0.01% 1769
2024
Q2 		$398K Buy
+14,643
New +$492K ﹤0.01% 1926

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TARS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tarsus Pharmaceuticals (TARS) stake by 3.5% in Q2 2026, buying an estimated $41.5K and bringing the position to 19,206 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Mirae Asset Global ETFs Holdings first reported a position in TARS in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.49M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 19,206 shares of Tarsus Pharmaceuticals worth $1.21M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 650 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $41.5K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1536 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Tarsus Pharmaceuticals position peaked at $1.49M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.